Ambit Meets brings together Life Sciences leaders to discuss digital transformation, Artificial Intelligence and regulatory compliance

Barcelona, June 3, 2026 – Professionals from leading Life Sciences companies gathered for a new edition of Ambit Meets: Tech Trends & Compliance in Life Sciences, Ambit Iberia’s annual event dedicated to fostering knowledge exchange, exploring emerging trends, and addressing the challenges shaping the future of the industry.

The event brought together key stakeholders from across the Life Sciences sector at a particularly significant moment for the industry. Digital transformation, the rapid adoption of artificial intelligence, and the evolving European regulatory landscape were among the central themes discussed throughout the day, all framed by a common objective: understanding how organizations can continue to innovate while maintaining the high standards of quality, traceability, and compliance required in highly regulated environments.

Discussions throughout the event highlighted the strategic importance of the pharmaceutical sector as one of the main drivers of innovation and industrial growth in Spain and across Europe. Participants also emphasized the growing need to attract, develop, and retain the talent required to lead the next phase of technological transformation within the industry.

One of the highlights of the event was the panel discussion “Operational Challenges and Scaling in the Pharma Industry,” featuring Juan Ignacio Alonso (Andersen), Jorge Castro (Applus+ Laboratories), Amaia Eguiazabal (EasyVista), Gerardo Barbosa (Multiplica), Marc Ramoneda (Appliant), and Unai Sancho (Agilent Technologies). The panelists shared their perspectives on business growth, process digitalization, operational efficiency, and change management, offering practical insights into how organizations can balance innovation with increasingly demanding regulatory requirements.

A practical industry perspective was provided by Cinfa, which presented a case study focused on the automation of its manufacturing facility in Pamplona. The company shared its experience implementing new industrial technologies, outlining both the challenges encountered during the process and the measurable impact that automation is having on operational efficiency and production capacity.

Artificial intelligence also featured prominently in the agenda. The panel discussion “AI in Healthcare & Pharma: From Potential to Regulatory Control” brought together Alfred Opisso (Roche), Francesc Paradell (Meribel Pharma), Christian Gay (Aizon), and Oriol Valls (Merck). The conversation explored the opportunities AI presents to accelerate processes, improve decision-making, and drive innovation, while also addressing key challenges related to model validation, data governance, human oversight, and compliance with the new regulatory frameworks currently being developed across Europe.

Beyond the panel sessions, attendees participated in a collaborative workshop designed to identify and discuss the priorities, barriers, and expectations that currently shape digital transformation initiatives within their organizations. The exercise provided a collective and realistic view of the sector’s current state, highlighting both areas of broad alignment and those that continue to present significant challenges.

A recurring theme throughout the event was the recognition that technology will continue to play a critical role in the evolution of the pharmaceutical industry. However, participants agreed that long-term success will depend on organizations’ ability to adopt and integrate new technologies responsibly, securely, and in alignment with the quality principles that define the sector.

Ambit Iberia expressed its sincere appreciation to all the individuals and organizations that contributed to the success of this edition of Ambit Meets.

Special recognition was given to the event sponsors, Spertoo and ValGenesis, whose support and commitment continue to help strengthen a collaborative environment for learning, innovation, and knowledge sharing within the Life Sciences ecosystem.

The company also thanked all speakers and participants for sharing their expertise and insights throughout the event. Their contributions enriched the discussions and provided valuable perspectives on the opportunities and challenges currently facing the industry.

Particular recognition was extended to Cinfa for presenting a real-world example of industrial transformation and offering attendees practical insights into the implementation of advanced manufacturing technologies.

Ambit Iberia also acknowledged the moderators and session hosts whose efforts facilitated engaging discussions and encouraged meaningful exchanges among participants.

Finally, the company thanked all attendees for their active participation, thoughtful contributions, and commitment to advancing dialogue within the sector. Their engagement once again reinforced Ambit Meets as a leading forum for collaboration and knowledge sharing, helping shape the future of digital transformation in Life Sciences.

As the event concluded, a clear message emerged: innovation, collaboration, and responsible technology adoption will remain essential drivers of progress across the pharmaceutical and Life Sciences industries. Ambit Iberia looks forward to welcoming participants to future editions of Ambit Meets, continuing to create opportunities for learning, networking, and exploring the trends that will define the sector in the years ahead.